Literature DB >> 25471697

Differential impact of the neutrophil-lymphocyte ratio on the survival of patients with stage IV gastric cancer.

Hiroaki Tanaka1, Kazuya Muguruma, Takahiro Toyokawa, Naoshi Kubo, Masaichi Ohira, Kosei Hirakawa.   

Abstract

BACKGROUND AND AIM: The neutrophil to lymphocyte ratio (NLR) may be related to progression in several cancers. The aim of this study was to investigate the impact of pretreatment NLR in advanced gastric cancer on the prognosis of the patients stratified by metastatic pattern.
METHODS: We retrospectively investigated clinical data from 191 patients with stage IV gastric cancer who had undergone surgery for primary gastric cancer between 1997 and 2010 at the Department of Surgical Oncology of Osaka City University.
RESULTS: All patients had unresectable metastatic factors including peritoneal metastasis (P) and liver metastasis (H). Sixty-one (32%) patients had more than two unresectable factors. We determined a cutoff value of 2.5 for the NLR to be optimal to discriminate the patient's characteristics and divided patients into low (<2.5) and high (>2.5) NLR group for subsequent analysis. In the low NLR group, long survival was found in patients with H, P, or multiple site metastases.
CONCLUSION: Our results suggest that NLR well reflects the progression of critical metastasis and surgical resection might improve prognosis for patients with low NLR. In conclusion, NLR might be used as a predictive marker to decide on surgical therapy for patients with Stage IV gastric cancer.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25471697     DOI: 10.1159/000369278

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  9 in total

1.  The prognostic significance of inflammation-based markers in patients with recurrent gastric cancer.

Authors:  Kazuhiro Migita; Sohei Matsumoto; Kohei Wakatsuki; Masahiro Ito; Tomohiro Kunishige; Hiroshi Nakade; Mutsuko Kitano; Mitsuhiro Nakatani; Masayuki Sho
Journal:  Surg Today       Date:  2017-08-23       Impact factor: 2.549

2.  The prognostic value of the systemic inflammatory score in patients with unresectable metastatic colorectal cancer.

Authors:  Masatsune Shibutani; Kiyoshi Maeda; Hisashi Nagahara; Tatsunari Fukuoka; Shinji Matsutani; Kenjiro Kimura; Ryosuke Amano; Kosei Hirakawa; Masaichi Ohira
Journal:  Oncol Lett       Date:  2018-05-04       Impact factor: 2.967

3.  Association between pretreatment Glasgow prognostic score and gastric cancer survival and clinicopathological features: a meta-analysis.

Authors:  Chun-Xiao Zhang; Shu-Yi Wang; Shuang-Qian Chen; Shuai-Long Yang; Lu Wan; Bin Xiong
Journal:  Onco Targets Ther       Date:  2016-06-27       Impact factor: 4.147

Review 4.  Neutrophil-to-lymphocyte ratio as prognostic indicator in gastrointestinal cancers: a systematic review and meta-analysis.

Authors:  Randy C Bowen; Nancy Ann B Little; Joshua R Harmer; Junjie Ma; Luke G Mirabelli; Kyle D Roller; Andrew Mackay Breivik; Emily Signor; Alec B Miller; Hung T Khong
Journal:  Oncotarget       Date:  2017-05-09

5.  Profiles Combining Muscle Atrophy and Neutrophil-to-Lymphocyte Ratio Are Associated with Prognosis of Patients with Stage IV Gastric Cancer.

Authors:  Kota Shigeto; Takumi Kawaguchi; Shunji Koya; Keisuke Hirota; Toshimitsu Tanaka; Sachiko Nagasu; Masaru Fukahori; Tomoyuki Ushijima; Hiroo Matsuse; Keisuke Miwa; Koji Nagafuji; Takuji Torimura
Journal:  Nutrients       Date:  2020-06-24       Impact factor: 5.717

6.  Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer.

Authors:  Sadayuki Kawai; Naoki Fukuda; Shun Yamamoto; Seiichiro Mitani; Katsuhiro Omae; Takeru Wakatsuki; Ken Kato; Shigenori Kadowaki; Daisuke Takahari; Narikazu Boku; Kei Muro; Nozomu Machida
Journal:  BMC Cancer       Date:  2020-04-21       Impact factor: 4.430

7.  Gastrectomy for stage IV gastric cancer: a comparison of different treatment strategies from the SEER database.

Authors:  Jacopo Desiderio; Andrea Sagnotta; Irene Terrenato; Bruno Annibale; Stefano Trastulli; Federico Tozzi; Vito D'Andrea; Sergio Bracarda; Eleonora Garofoli; Yuman Fong; Yanghee Woo; Amilcare Parisi
Journal:  Sci Rep       Date:  2021-03-30       Impact factor: 4.379

8.  Using the preoperative prognostic nutritional index as a predictive factor for non-cancer-related death in post-curative resection gastric cancer patients: a retrospective cohort study.

Authors:  Hitomi Takechi; Nobuaki Fujikuni; Kazuaki Tanabe; Minoru Hattori; Hironobu Amano; Toshio Noriyuki; Masahiro Nakahara
Journal:  BMC Gastroenterol       Date:  2020-08-05       Impact factor: 3.067

9.  Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study.

Authors:  Takatsugu Ogata; Hironaga Satake; Misato Ogata; Yukimasa Hatachi; Kentaro Inoue; Madoka Hamada; Hisateru Yasui
Journal:  Oncotarget       Date:  2018-10-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.